146 related articles for article (PubMed ID: 6214058)
21. Effects of repeated, small aliquot, same donor transfusions of HL-A defined blood on prospective recipients.
Burrows L; Schanzer H; Miller C; Giannone G; Feingold R; Fotino M; Rubenstein P
Transplant Proc; 1982 Jun; 14(2):272-5. PubMed ID: 7051465
[TBL] [Abstract][Full Text] [Related]
22. HLA-DR typing and B cell cross-match tests in cadaveric renal transplantation.
Albrechtsen D; Flatmark A; Halvorsen S; Jervell J; Solheim BG; Thorsby E
Scand J Urol Nephrol Suppl; 1980; 54():25-8. PubMed ID: 7013036
[TBL] [Abstract][Full Text] [Related]
23. Pretreatment of renal allograft recipients with azathioprine and donor-specific blood products.
Anderson CB; Sicard GA; Etheredge EE
Surgery; 1982 Aug; 92(2):315-21. PubMed ID: 7048600
[TBL] [Abstract][Full Text] [Related]
24. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
25. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
[TBL] [Abstract][Full Text] [Related]
26. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
27. Kidney transplantation, the Halifax experience.
Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
[TBL] [Abstract][Full Text] [Related]
28. Improved kidney graft survival through HLA-DR-MT matching.
Müller GA; Müller C; Wernet P
Proc Eur Dial Transplant Assoc; 1983; 19():464-8. PubMed ID: 6348746
[TBL] [Abstract][Full Text] [Related]
29. [Immunologic selection of renal transplant donors and recipients: blood transfusions].
Seignalet J; Mourad G; Mion C
Nephrologie; 1984; 5(3):123-9. PubMed ID: 6387521
[TBL] [Abstract][Full Text] [Related]
30. Histocompatibility testing in clinical renal transplantation.
Braun WE
Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529
[No Abstract] [Full Text] [Related]
31. Cadaver kidney allocation in the north Italy transplant program on the eve of the new millennium.
Sirchia G; Poli F; Cardillo M; Scalamogna M; Rebulla P; Taioli E; Remuzzi G; Nocera A
Clin Transpl; 1998; ():133-45. PubMed ID: 10503092
[TBL] [Abstract][Full Text] [Related]
32. Effect of donor-specific transfusions on the outcome of renal allografts in the cyclosporine era.
Marti HP; Henschkowski J; Laux G; Vogt B; Seiler C; Opelz G; Frey FJ
Transpl Int; 2006 Jan; 19(1):19-26. PubMed ID: 16359373
[TBL] [Abstract][Full Text] [Related]
33. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.
Jordan SC; Vo A; Bunnapradist S; Toyoda M; Peng A; Puliyanda D; Kamil E; Tyan D
Transplantation; 2003 Aug; 76(4):631-6. PubMed ID: 12973100
[TBL] [Abstract][Full Text] [Related]
34. Effect of HLA-DR matching between living kidney donors and recipients and of pretransplant blood transfusions on graft survival.
Akiyama N; Sugimoto H; Kusaba R; Takahashi I; Ohsawa N; Inou T; Samaru Y
Jpn J Exp Med; 1981 Feb; 51(1):37-43. PubMed ID: 6458714
[TBL] [Abstract][Full Text] [Related]
35. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
[TBL] [Abstract][Full Text] [Related]
36. Kidney transplantation in the United States.
Cecka JM
Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
[TBL] [Abstract][Full Text] [Related]
37. Beneficial effects of donor-specific transfusions on long-term renal allograft function.
Anderson CB; Brennan D; Keller C; Goss J; Shenoy S; Burton K; Sicard G; Flye MW
Transplant Proc; 1995 Feb; 27(1):991-4. PubMed ID: 7879258
[TBL] [Abstract][Full Text] [Related]
38. The UNOS scientific renal transplant registry. United Network for Organ Sharing.
Cecka JM; Terasaki PI
Clin Transpl; 1995; ():1-18. PubMed ID: 8794251
[TBL] [Abstract][Full Text] [Related]
39. Donor-specific blood transfusions (DST): clinical outcome and immunologic considerations.
Fujiwara T; Sakagami K; Haisa M; Kusaka S; Uda M; Kobayashi N; Tanakaya K; Saito S; Matsuno T; Matsuoka J
Transplant Proc; 1992 Aug; 24(4):1427-8. PubMed ID: 1386699
[No Abstract] [Full Text] [Related]
40. [The significance of mixed lymphocyte culture and mitogen-stimulated culture for kidney transplantation (author's transl)].
Hajek-Rosenmayr A; Wolf A
Wien Klin Wochenschr; 1981 Jul; 93(14):457-60. PubMed ID: 6455859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
